News and Announcements
tagSpace Pty Ltd Enjoys Growth via International Partnerships
- Published November 24, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
tagSpace is pleased to announce a leap in growth and PR in the USA and Australia via new commercial partnerships. In the last month, they have signed partnership deals with two new agencies in the USA, gotten 8 new expressions of interest and joined their unicorn partners, Clique for their official API launch into the Australian market.
In addition, tagSpace recently launched the Alpha version of its new user analytics suite for their tagStorm mixed-reality platform. This gives businesses for the first time a true end-to-end product allowing them to Create, Place, Publish and then Analyse the success of mixed-reality experiences for their clients.
tagSpace market: The Mixed-reality market is currently estimated by IDC and Digi-Capital to be worth $60B with recent numbers by Deloitte predicting a new trillion-dollar industry in augmented-reality for marketing. It is experiencing massive growth and forecast by those same analysists to grow to more than $200B by 2021 with major players such as Google, Facebook, Microsoft and Apple making serious strategic acquisitions in this arena.
About tagSpace
tagSpace is a technology start-up developing a software platform called tagStorm that powers Mixed Reality, Social Media and Marketing capabilities on today’s smartphones. They were recently announced as the top trending AR company in New South Wales by Techboard: https://techboard.com.au/techboard-ranking-sector-spotlight-july-2017-augmentedvirtual-reality-companies/
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
